Products

What will AGI do for Bepotastine besilate?

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H25CLN2O3.C6H6O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6W18MO1QR3. European Medicines Agency schedules bepotastine besilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05778MIG. The term bepotastine besilate is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule bepotastine besilate under HS 29333999 and SITC 51574. As of Q4 2014, BEPOTASTINE BESILATE remains US FDA's Preferred Term for this commodity. Bepotastine besilate bears US NLM identifiers UMLS ID C1723019 and NCI Concept Code C83550. SMILES: C1CCC(CC1)S(=O)(=O)O.C1CCNC(C1)[C@H](C2CCC(CC2)CL)OC3CCN(CC3)CCCC(=O)O.